Adjunctive armodafinil for negative symptoms in adults with schizophrenia: a double-blind, placebo-controlled study.

@article{Kane2012AdjunctiveAF,
  title={Adjunctive armodafinil for negative symptoms in adults with schizophrenia: a double-blind, placebo-controlled study.},
  author={John M. Kane and Ronghua Yang and James M Youakim},
  journal={Schizophrenia research},
  year={2012},
  volume={135 1-3},
  pages={116-22}
}
OBJECTIVE A prior 4-week, proof-of-concept study suggested that adjunctive therapy with armodafinil 200mg/day decreases negative symptoms in patients with clinically stable schizophrenia. This study investigated the efficacy and tolerability of adjunctive armodafinil for treatment of negative symptoms in adults with schizophrenia receiving antipsychotic medications. METHODS This parallel-group, 24-week study enrolled adults with schizophrenia who were receiving oral olanzapine, risperidone… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Armodafinil induced mania in schizophrenia.

The Australian and New Zealand journal of psychiatry • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…